Otezla is the first and only oral therapy approved across all severities of adult plaque psoriasis SEE THE DATA
Otezla is covered by most health plans in the US, including commercial, Medicare, and Medicaid. 1
Amgen Inc. continually works to expand the number and location of insurance plans that cover the cost of Otezla. Please reach out to your Otezla sales representative for more information on local coverage.
The Otezla SupportPlus™ program offers multiple resources for you and your patients, including insurance and reimbursement support. Financial assistance options are available to patients who face a wide variety of insurance scenarios:
Click here to learn more about Otezla SupportPlus™ or contact your Otezla representative to discuss which financial assistance program may be appropriate for your patient.
The Resource Center provides information to help start your patients on Otezla, to verify their insurance benefits, and to support their treatment. The Resource Center provides downloadable materials and guidance such as the prescription start form, a form to obtain a letter of medical necessity, an application for financial assistance for patients, and educational materials for patients.
If you have questions related to pharmacy benefit management procedures, please contact Otezla SupportPlus™ (1-844-4OTEZLA)
8 AM – 8 PM ET, Monday – Friday.
Request a rep for more information if the insurance plan that you seek is not included.
Warnings and Precautions
Use in Specific Populations
Please click here for the full Prescribing Information.
Otezla® (apremilast) is indicated for the treatment of adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy.
Otezla is indicated for the treatment of adult patients with active psoriatic arthritis.
Otezla is indicated for the treatment of adult patients with oral ulcers associated with Behçet’s Disease.